Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.47 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.47 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.47 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.43 |
| ▸ | FDPS | P14324 | 4/20 | 0.42 |
| ▸ | TRPM8 | Q7Z2W7 | 7/20 | 0.41 |
| ▸ | LAP3 | P28838 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10885135 | 0.87 | LPAR3 (0.47) | CYP3A4LPAR3LPAR1LPAR2TRPM8 | |
| SCHEMBL15353194 | 0.86 | SMPD1 (0.44) | LPAR3LPAR1LPAR2SMPD1FDPS | |
| SCHEMBL7804487 | 0.82 | CYP3A4 (0.54) | CYP3A4LPAR3LPAR1LPAR2TRPM8 | |
| SCHEMBL7804496 | 0.81 | LPAR3 (0.53) | CYP3A4LPAR3LPAR1LPAR2SMPD1 | |
| SCHEMBL27984266 | 0.78 | LPAR3 (0.53) | CYP3A4LPAR3LPAR1LPAR2SMPD1 | |
| SCHEMBL2969240 | 0.78 | CYP3A4 (0.50) | CYP3A4LPAR3LPAR1LPAR2TRPM8 | |
| SCHEMBL28131538 | 0.78 | LPAR3 (0.57) | CYP3A4LPAR3LPAR1LPAR2TRPM8 | |
| SCHEMBL20365387 | 0.77 | CYP3A4 (0.38) | CYP3A4LPAR3LPAR1LPAR2LAP3 | |
| SCHEMBL13618652 | 0.77 | CYP3A4 (0.58) | CYP3A4LPAR3LPAR1LPAR2TRPM8 | |
| SCHEMBL11030588 | 0.77 | SMPD1 (0.47) | SMPD1FDPSTRPM8LAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010025116-A1 | Aluminum salts of phosphinic acids | TICONA GMBH | 2001-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010025116-A1 | Aluminum salts of phosphinic acids | PPA1, PHOSPHO1, AGPS | CYP3A4 4686/4885LPAR3 1176/4885LPAR1 577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.